MARKER THERAPEUTICS, INC. Convertible Notes Payable, Current
MARKER THERAPEUTICS, INC. (MRKR) had Convertible Notes Payable, Current of $434.53 thousand as of 2014-03-31, per its 10-Q/A filed 2014-05-21.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Debt, Current › Notes and Loans Payable, Current › Notes Payable, Current
us-gaap:ConvertibleNotesPayableCurrent · last filed 2015-04-15
- 2014-03-31: Convertible Notes Payable, Current $434.53K.
- 2013-12-31: Convertible Notes Payable, Current $3.16M.
- 2013-09-30: Convertible Notes Payable, Current $2.35M.
- 2013-03-31: Convertible Notes Payable, Current $2.06M.
| Period end | Convertible Notes Payable, Current | Convertible Notes Payable, Current as first filed |
|---|---|---|
| 2014-03-31 | $434.53K 10-Q/A · filed 2014-05-21 | |
| 2013-12-31 | $3.16M 10-K · filed 2015-04-15 | |
| 2013-09-30 | $2.35M 10-Q · filed 2013-11-19 | |
| 2013-03-31 | $2.06M 10-Q/A · filed 2013-08-19 | |
| 2012-12-31 | $1.48M 10-K/A · filed 2014-04-17 | $1.38M 10-K · filed 2013-05-15 |
| 2012-09-30 | $1.18M 10-Q · filed 2012-11-19 | |
| 2012-06-30 | $1.10M 10-Q/A · filed 2012-09-12 | |
| 2012-03-31 | $1.05M 10-Q · filed 2012-05-21 | |
| 2011-12-31 | $998.79K 10-K · filed 2013-05-15 | |
| 2010-12-31 | $353.05K 10-K · filed 2012-04-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |